Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Sexual function in patients supported with left ventricular assist device and with heart transplant
Tal Hasin1,2, Tiny Jaarsma3, Daniel Murninkas1
1Cardiology Department, Rabin Medical Center, Petah Tikva, Israel.
Insights
Sexual dysfunction is common in patients with left ventricular assist devices (LVADs), impacting quality of life more than after heart transplantation (HTx). Addressing physiological, psychological, and equipment issues is crucial for LVAD patients.
Area of Science:
- Cardiology
- Urology
- Psychology
Background:
- Sexual dysfunction is prevalent in heart failure (HF) patients, affecting quality of life.
- Left ventricular assist device (LVAD) implantation improves survival in advanced HF, but its effect on sexual function is understudied.
- Heart transplantation (HTx) is an alternative treatment for advanced HF.
Purpose of the Study:
- To evaluate sexual function in patients with LVAD support.
- To compare sexual function between LVAD patients and patients after HTx.
- To identify factors contributing to sexual dysfunction in LVAD recipients.
Main Methods:
- A validated questionnaire and visual analogue scale assessed sexual activity and satisfaction in stable LVAD and HTx patients.
- Data were collected from 31 patients (17 HTx, 14 LVAD).
- Statistical analysis compared outcomes between the two groups.
Main Results:
- Sexual satisfaction was significantly higher in HTx patients (7.6/10) compared to LVAD patients (3.9/10).
- Only 29% of LVAD patients reported satisfaction with sexual activity, versus 71% of HTx patients.
- Common issues for LVAD patients included erectile dysfunction, vaginal dryness, device-related problems, and orgasmic difficulties.
Conclusions:
- Sexual dysfunction is a significant issue for LVAD patients, potentially more pronounced than after HTx.
- Physiological, psychological, and device-related factors contribute to sexual problems in LVAD recipients.
- Comprehensive follow-up care for LVAD patients should address sexual health concerns.
Aims:
Sexual dysfunction is common among patients with heart failure (HF) and considered an important hamper to quality of life. While implantation of left ventricular assist device (LVAD) may prolong and improve life in advanced HF, limited data are available on its impact on sexual function. The aim of this study is to evaluate sexual function in LVAD patients and compare this with patients after heart transplantation (HTx).
Methods And Results:
Sexual activity and satisfaction of stable patients with durable LVAD or after HTx were evaluated using a validated questionnaire and visual analogue scale from 0 to 10. Data were collected from 31 patients (mean age 59 ± 12 years, 87% male), 17 after HTx and 14 with LVAD. Pleasure or satisfaction with sex was significantly higher in HTx patients (P = 0.0005). In total, 29% LVAD patients and 71% HTx patients reported content with sexual activity. Recalled satisfaction with sex life pre-operation was comparable between the groups. During support, satisfaction with sex life using visual analogue scale was 7.6 ± 3.1 for HTx versus 3.9 ± 4.0 for LVAD patients (P = 0.017). In total, 11 LVAD patients (79%) reported specific problems in sexual function including erectile dysfunction or vaginal dryness (8, 57%); problems with the LVAD, cable, or batteries (5, 36%); problems with orgasm (4,29%); and other problems such as fear of injury, feeling depressed, partner issues, self-image, and pain (1, 7% each).
Conclusion:
Sexual dysfunction occurs in patients with LVAD support and may be more prominent than after HTx. Problems limiting sexual function related to physiological, psychological, and equipment merit consideration during follow-up.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
08:21Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
Published on: October 11, 2022
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy